GordonMD Global Investments LP disclosed on October 9, 2026, that it had significantly increased its position in Pyxis Oncology. The firm acquired nearly 18 million shares on October 1, bringing its total holding to almost 28 million shares.
The purchase was part of a public offering that Pyxis Oncology closed on October 1, 2026.
Pyxis Oncology’s stock has posted a significant year-to-date return but has declined since the transaction date. The stock’s volatility highlights the risks associated with the sector.